SMAD4 and neoplasm: Using this model, Hernandez et al. spotted a marked heterogeneity in SMAD4 deletions in HNSCC patients, both inter- and intra-tumour, and demonstrated that the SMAD4 FISH assay could be used as diagnosis tool to assess chromosomal loss which could be associated with prognosis in these patients [78].